T1	Participants 52 119	type 2 diabetic patients with late failure of sulphonylurea therapy
T2	Participants 229 258	patients with type 2 diabetes
T3	Participants 447 583	type 2 diabetic patients with late-term failure following at least 3 years of sulphonylurea therapy requiring additional insulin therapy
T4	Participants 751 791	patients who achieve a decrease in HbA1c
T5	Participants 1470 1492	acarbose-treated group
T6	Participants 1618 1632	acarbose group
T7	Participants 1941 1965	type 2 diabetic patients
